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Recognition of proximally phosphorylated tyrosine residues and 
continuous analysis of phosphatase activity using a stable europium 
complex 
The recognition of proteins and their post-translational modifications using 
synthetic molecules is an active area of research. A common post-translational 
modification is the phosphorylation of serine, threonine or tyrosine residues. The 
phosphorylation of proximal tyrosine residues occurs in over 1000 proteins in the 
human proteome, including in disease-related proteins, so the recognition of this 
motif is of particular interest. We have developed a luminescent europium(III) 
complex, [Eu.1]+, capable of the discrimination of proximally phosphorylated 
tyrosine residues, from analogous mono- and non-phosphorylated tyrosine 
residues, more distantly-related phosphotyrosine residues and over proximally 
phosphorylated serine and threonine residues. [Eu.1]+ was used to continuously 
monitor the phosphatase catalysed dephosphorylation of a peptide containing 
proximally phosphorylated tyrosine residues. 
Keywords: anion sensing; luminescence; europium; phosphorylation; enzyme 
assay 
Introduction 
The detection and discrimination of proteins and their post-translational 
modifications using synthetic molecules is an active area of research.1-4 Traditional 
approaches for the discrimination of proteins involve the use of enzyme and antibody 
responses (for example using ELISA),5 which can be cumbersome and expensive. 
Synthetic molecules may offer advantages in terms of stability, their tunable 
luminescence properties and their potentially cheaper preparation. One post-
translational modification of particular importance is the phosphorylation of serine, 
threonine and tyrosine residues, which acts as key regulators of protein function and 
signalling within biological systems.6 The study of the phosphorylation and 
dephosphorylation of proteins, catalysed by kinases and phosphatases respectively, is of 
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critical importance both for the understanding of biological processes and facilitating 
drug discovery. 
The phosphorylation of tyrosine residues is less common (~1%) compared to 
that of serine (~90%) or threonine (~4%) residues. However, the phosphorylation of 
proximal tyrosine residues occurs in over 1000 proteins in the human proteome,7 
including in disease-related proteins such as JAK2 and IGFR proteins. Therefore, the 
development of synthetic probes for the detection of proximal phosphotyrosine (pY) 
residues within peptides and proteins, with minimal interference from phosphoserine 
(pS) or phosphothreonine (pT) residues, could be useful for more specific sensing of 
these proteins. Additionally, such probes could be used for screening of new drugs for 
the treatment of diseases caused by abnormal phosphorylation. 
The detection of phosphorylated amino acid residues within peptides and 
proteins has been achieved using discrete emissive metal complexes, including Zn(II),8-
11 Cu(II),12 Tb(III),13-14 and Eu(III) complexes,15-16 whereby coordination of the 
phosphorylated residue to the metal complex induces a measurable change in 
luminescence. However, these probes often show very little sequence specificity or 
selectivity between phosphorylated amino acid residues. Some sensing selectivity has 
been achieved for certain phosphorylation patterns, including proximally 
phosphorylated tyrosine residues. The Hamachi group have worked extensively with 
Zn(II)-dipicolyamine complexes for the detection of phosphorylated peptides and have 
utilised selected probes for both end-point phosphatase assays and real-time 
monitoring.8, 10, 17 Gunning and coworkers prepared a fluorescent Zn(II)–cyclen 
complex for the detection of proximal di- and triphosphorylated proteins,11 
demonstrating its ability to discriminate proteins on a polyacrylamide gel. However, this 
probe cannot discriminate proximal pY residues (pYpY motifs) from peptides 
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containing a pYXpY motif (where X is any amino acid) nor a pYpT motif,18 with 
similar spectral responses reported. Increased specificity for a target phosphorylated 
peptide has been achieved by conjugation of various emissive metal complexes to a 
designed peptide or protein;19-25 however, this approach involves additional non-trivial 
synthetic processes. 
Herein we report the use of a stable europium(III) complex, [Eu.1]+ (Figure 1a), 
for the detection of proximally phosphorylated tyrosine residues within a peptide, and 
demonstrate the probe’s utility in monitoring an acid phosphatase catalysed 
dephosphorylation reaction in real-time. The use of a discrete luminescent Eu(III) 
complex for phosphopeptide recognition and monitoring enzyme activity offers several 
advantages, including line-like emission spectra that permits ratiometric detection, large 
pseudo Stokes’ shifts and the potential for time-resolved emission spectra, permitting 
complete removal of background autofluorescence arising from peptide or protein 
substrates.25-32 
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Figure 1. a) Structure of complex [Eu.1]+; b) Different peptides used in this study; c) 
Cartoon representation of the proposed binding mode of [Eu.1]+ to peptides containing 
the pYpY motif.  
 
We have previously reported the synthesis33 and application of [Eu.1]+ for the 
detection of nucleotide polyphosphate anions,34 using the probe to monitor the ratio of 
ADP/ATP during the kinase catalysed phosphorylation of a serine containing peptide. 
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We now report another application for this Eu(III) complex: the luminescent detection 
of proximally phosphorylated tyrosine (pYpY) residues within peptides. This spectral 
response of [Eu.1]+ is distinct compared to mono- and non-phosphorylated tyrosine 
residues (YpY and YY), proximally phosphorylated serine (pSpS) and threonine (pTpT) 
residues and more distant phosphorylated tyrosine residues (e.g. pYApY and 
pYAApY). The excellent discriminatory behaviour of [Eu.1]+ allowed the phosphatase 
catalysed dephosphorylation of a proximally phosphorylated peptide, ApYpYAA, to be 
monitored in real-time. 
Results and Discussion 
Discrimination of proximally phosphorylated tyrosine residues 
 
Figure 2. a) Luminescence response of [Eu.1]+ (8 µM) in the presence of different 
phosphotyrosine containing peptides (10 mM); b) Titration of ApYpYAA (0–8 mM) 
into [Eu.1]+ (8 µM). Conditions: 10 mM HEPES, pH 7.0, λexc = 330 nm  
 
Figure 2a shows the change in emission intensity of [Eu.1]+ in the presence of 
various phosphotyrosine containing peptides (10 mM), measured in aqueous buffer (10 
mM HEPES) at pH 7.0. Addition of the proximally phosphorylated peptide, 
ApYpYAA, resulted in a striking increase in Eu(III) emission intensity and a 
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pronounced change in spectral form. The emission spectral response was much lower 
for the other peptides tested, including the analogous mono- and non-phosphorylated 
peptides, AYpYAA and AYYAA, a proximally triphosphorylated peptide ApYpYpYA, 
and a diphosphorylated peptide bearing two pY residues separated by a single alanine 
residue (ApYApYA). The distinctive response to the pYpY containing peptide lead us 
to explore the use of [Eu.1]+ for the recognition of the pYpY motif over a wider range 
of different phosphorylated peptides.  
 
Figure 3. Change in the emission intensity ratio of [Eu.1]+ (8 µM) at 612/599 nm upon 
incremental addition of: a) various phosphotyrosine (pY) containing peptides; b) 
proximally diphosphorylated tyrosine, serine and threonine containing peptides. 
Conditions: 10 mM HEPES buffer, pH 7.0, λexc = 330 nm. 
 
A titration of the proximally phosphorylated tyrosine peptide, ApYpYAA, into 
[Eu.1]+ caused a rapid increase in intensity of the ΔJ = 2 emission band centred around 
614 nm (Figure 2b). In sharp contrast, titrations of a range of other phosphopeptides 
resulted in much smaller changes in Eu(III) emission intensity (Figure S1). The high 
sensing selectivity for the peptide ApYpYAA can be visualised clearly by following the 
ratiometric change in intensity at 612/599 nm as a function of peptide concentration 
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(Figure 3a). Addition of ApYpYAA (0–8 mM) caused a 10-fold enhancement in the 
emission intensity ratio, whereas the mono- and non-phosphorylated peptides 
(AYpYAA and AYYAA, respectively) induced less than 10% increases in the 
ratiometric signal. Similarly, only minor increases in the emission intensity were 
observed upon addition of peptides containing two more distantly related 
phosphotyrosine residues (i, i+2 for ApYApYA, or i, i+3 for pYAApYA). This is 
significant, as previously reported synthetic probes exhibited limited selectivity between 
peptides containing differentially located phosphorylated residues.18, 35-37 Importantly, 
replacing one of the pY residues with a negatively charged glutamic acid residue 
(ApYEAA or ApYAEA, both purple in Figure 3a), resulted in minimal increases in the 
intensity ratio at 612/599 nm upon titration of these peptides. These results demonstrate 
that the presence of a pYpY motif is essential for the distinctive response of [Eu.1]+, 
rather than there simply being a requirement for two adjacent negatively charged amino 
acid residues.  
Table 1. Luminescence lifetimes in H2O and D2O (10 mM HEPES, pH 7.0) and 
calculated q values for [Eu.1]+ (30 µM) alone and in the presence of AYYAA, 
AYpYAA and ApYpYAA (all 9 mM); λexc = 330 nm, λem = 615 nm. 
peptide τH2O / ms τD2O / ms qa 
none 0.55 1.22 0.8 
AYYAA 0.68 1.30 0.5 
AYpYAA 0.72 1.21 0.3 
ApYpYAA 0.89 1.27 0.1 
aValues of hydration state, q ( ︎20%) are derived using methods in ref. 38.  
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The discrimination of the pYpY motif is likely to arise from both higher affinity 
binding and a distinctive binding mode to the Eu(III) complex. When the two proximal 
pY residues are present, it is hypothesised that both phosphate groups coordinate to the 
Eu(III) metal, causing displacement of the bound water molecule and potentially one of 
the coordinated quinoline arms, allowing multi-dentate binding (Figure 1c). Evidence 
for a change in coordination environment of the Eu(III) metal is given by a change in 
the structure of the hypersensitive ΔJ = 2 band and an increase in the emission lifetime 
of [Eu.1]+ in the presence of ApYpYAA compared to the Eu(III) complex alone (Table 
1). Calculation of hydration state, q, indicates displacement of the bound water 
molecule from [Eu.1]+ on incubation with the ApYpYAA peptide (Table 1).38   A 
smaller increase in the emission lifetime of [Eu.1]+ in the presence of the AYYAA and 
the AYpYAA peptide compared to the Eu(III) complex alone, is also observed, with the 
non-integral q values indicating formation of ‘partially’ hydrated species on incubation 
with these peptides.  These peptides also induce small changes in the spectral form of 
the ΔJ = 2 band of [Eu.1]+, but minimal changes in the ΔJ = 1 band, compared to 
pronounced changes in both bands on incubation with ApYpYAA (Figure S2). This 
indicates a change in ligand field on incubation with all three peptides, however the 
different spectral changes, along with the larger change in q in the presence of 
ApYpYAA indicate a different binding mode.  Furthermore, it is reasonable to suggest 
that this binding mode may only be possible when two proximal pY residues are present 
in the peptide, as further spacing between pY residues results in less favourable entropy 
of binding, as seen by the minimal changes in spectral form upon addition ApYApYA 
and ApYAApY. 
Next, we examined the ability of [Eu.1]+ to distinguish between peptides 
bearing proximal pY, pS and pT residues. Titrations of peptides bearing proximally 
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phosphorylated serine and threonine residues (ApSpSAA and ApTpTAA) caused 
approximately 4-fold enhancements in the 612/599 nm emission intensity ratio of 
[Eu.1]+, significantly lower than the analogous diphosphotyrosine peptide, ApYpYAA 
(Figure 3b and Figure S3). Thus, [Eu.1]+ can be used to detect peptides containing 
proximal pY residues over proximal pS or pT residues. This could be attributed to a 
change in the orientation of the phosphate groups compared to the peptide backbone and 
the potential for π-π stacking between the coordinated pY residues and the quinoline 
arms of the Eu(III) complex. Differences in the binding orientation between the 
diphosphorylated peptides is indicated by the clear differences in fine splitting of the ΔJ 
= 1 emission band (Figure S4).39 Additionally, the lower desolvation energy of pY 
residues compared to pS or pT residues is expected to contribute towards the overall 
free energy of binding of pYpY containing peptides to [Eu.1]+.  
 
Continuous monitoring of a phosphatase enzyme reaction 
Having shown that [Eu.1]+ can distinguish a peptide containing proximal pY residues 
from other non-phosphorylated, monophosphorylated and diphosphorylated peptides, 
we wished to utilise the probe to monitor a phosphatase-catalysed dephosphorylation 
reaction. For this proof-of-concept enzyme reaction we used acid phosphatase, an 
enzyme which catalyses the hydrolysis of phosphate monoesters, including from pY, pS 
and pT residues, within the pH range 4.0 – 7.0.  The enzyme is therefore expected to 
remove both the phosphate groups from the ApYpYAA peptide, forming AYYAA via 
either ApYYAA or AYpYAA.  
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Figure 4. Model of the phosphatase reaction, by titrating peptide AYYAA (0 – 3.4 mM) 
into a solution containing ApYpYAA (4 mM initially) and [Eu.1]+ (8 µM), monitoring 
the change in emission intensity. a) Change in emission spectra of [Eu.1]+; b) Change in 
the emission intensity at 614 nm over the whole titration (upper) and in the linear range 
(lower); c) Change in the intensity ratio at 614/599 nm over the whole titration (upper) 
and in the linear range (lower). Conditions: 10 mM HEPES buffer, pH 7.0, λexc = 330 
nm. 
 
Before pursuing the enzyme reaction, we modelled the change in Eu(III) 
emission spectra that might be expected during the enzymatic conversion of peptide 
ApYpYAA to both the mono- and non-phosphorylated analogues, AYpYAA and 
AYYAA (Figure S5 and Figure 4, respectively). Titrations of AYpYAA or AYYAA 
into ApYpYAA, in the presence of [Eu.1]+ resulted in measurable decreases in the 
intensity of the ΔJ = 2 emission band (Figure 4a and Figure S5a), accompanied by 
pronounced changes in spectral form. Specifically, the intense single component ΔJ = 2 
band, characteristic of the bound diphosphorylated peptide, changed gradually to the 
less intense, two-component band associated with each of the other peptides. Following 
the emission intensity at 614 nm (Figure 4b), a decrease in intensity was seen upon 
addition of AYpYAA or AYYAA to ApYpYAA, which was approximately linear up to 
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50 % conversion. The simulated dephosphorylation can also be followed 
ratiometrically, by monitoring the change in the intensity ratio at 614/599 nm (Figure 4c 
and Figure S5c).  A simulation of the second dephosphorylation event, involving 
conversion of the mono-phosphorylated peptide AYpYAA to the non-phosphorylated 
peptide AYYAA, was followed in a similar manner, showing minimal changes in 
emission spectra (Figure S6). Based on these experiments, it was anticipated that in 
monitoring the enzyme-catalysed dephosphorylation of ApYpYAA, the predominant 
observation would be the first dephosphorylation, with minor fluctuations in emission 
intensity being observed for the second dephosphorylation. The byproduct of 
dephosphorylation is inorganic phosphate, and titration of this species into [Eu.1]+, in 
the presence of AYYAA, caused a minimal change in emission intensity and spectral 
form of [Eu.1]+ (Figure S7a). Thus, the accumulation of inorganic phosphate during the 
enzyme reaction was not expected to interfere with the ability of [Eu.1]+ to signal the 
dephosphorylation process. Similarly, addition of the acid phosphatase enzyme to 
[Eu.1]+ also caused negligible changes in the emission spectra of [Eu.1]+ (Figure S7b). 
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Figure 5. Luminescence monitoring of the acid phosphatase (0.5 units mL-1) catalysed 
dephosphorylation of ApYpYAA (8 mM) using [Eu.1]+ (8 µM). a) Change in the 
emission spectrum of [Eu.1]+ (570–630 nm); b) Change in Eu(III) emission intensity at 
614 nm in the presence and absence of enzyme (4 mM ApYpYAA), referenced against 
the non-phosphorylated peptide AYYAA (4 mM). Conditions: 10 mM HEPES buffer, 
pH 7.0, λexc = 330 nm. 
Next, we used [Eu.1]+ to monitor the acid phosphatase catalysed 
dephosphorylation of ApYpYAA in real-time. Incubation of ApYpYAA (8 mM) with 
acid phosphatase (0.5 units mL-1) resulted in a decrease in the intensity of the ΔJ = 2 
band of [Eu.1]+ over time (Figure 5a). A plot of the change in intensity at 614 nm as a 
function of time revealed a rapid decrease in the emission intensity of [Eu.1]+, with the 
rate of intensity decrease slowing over time, as expected for the dephosphorylation of 
the peptide (Figure 5b). In the absence of enzyme, the rate of emission intensity 
decrease was much slower, and can be attributed to the background hydrolysis of 
peptide ApYpYAA. As a control, the emission intensity of [Eu.1]+ in the presence of 
the non-phosphorylated peptide AYYAA remained constant over the time, indicating 
minimal photobleaching of [Eu.1]+ during the timeframe of the experiment (Figure 5b).  
The magnitude of the observed decrease in Eu(III) emission intensity in the 
presence of acid phosphatase was lower than that expected based on the titration of 
either AYYAA or AYpYAA into the ApYpYAA peptide. This could be due to the 
dephosphorylation reaction not reaching completion in the time frame studied, with 
some ApYpYAA remaining at the end of the experiment. This is presumably as a result 
of inhibition of the phosphatase enzyme by the byproduct, inorganic phosphate, a 
known inhibitor of the enzyme.  
Having demonstrated that it was possible to monitor acid phosphatase activity, 
the reaction was followed at 3 different enzyme concentrations (Figure 6). Pleasingly, 
the rate of hydrolysis of ApYpYAA increased with increasing concentrations of 
 
13 
enzyme. A plot of the initial rates of reaction revealed linear responses over the first 8 
minutes (Figure 6b), which would allow for initial enzyme reaction rates to be 
determined. This demonstrates the utility of [Eu.1]+ for monitoring the acid phosphatase 
catalysed hydrolysis of proximally phosphorylated tyrosine residues in real-time. 
 
Figure 6. Monitoring of the acid phosphatase catalysed dephosphorylation of 
ApYpYAA (4 mM) using [Eu.1]+ (8 µM), using different enzyme concentrations. a) 
Change in Eu(III) emission intensity at 614 nm over time at the three different enzyme 
concentrations (0.1, 0.5 and 2.5 units mL-1); b) Initial rates of hydrolysis, showing linear 
responses over at least the first 8 minutes. Conditions: 10 mM HEPES buffer, pH 7.0, 
λexc = 330 nm. 
Conclusion 
A stable luminescent Eu(III) complex, [Eu.1]+, has been shown to discriminate 
proximally phosphorylated tyrosine residues in peptides under neutral aqueous 
conditions, from the analogous mono- and non-phosphorylated peptides, as well as 
differentially located phosphotyrosine residues and proximally phosphorylated serine 
and threonine residues. The excellent discriminatory behaviour of the Eu(III) complex 
allowed its application in a continuous-read enzyme assay, wherein the phosphatase 
catalysed dephosphorylation of a peptide containing a pYpY motif was monitored in 
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real-time, without the need to chemically modify the enzyme or its substrate. Future 
work will be directed towards the recognition of proximally phosphorylated tyrosine 
residues in more biologically and therapeutically important peptides and proteins, 
tracking their dephosphorylation by using more substrate-specific phosphatase enzymes. 
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